List of Tables
Table 1. Global Precision Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cancer Immunotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Global Precision Cancer Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Precision Cancer Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Precision Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Precision Cancer Medicine Market Share by Region (2019-2024)
Table 8. Global Precision Cancer Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Precision Cancer Medicine Market Share by Region (2025-2030)
Table 10. Precision Cancer Medicine Market Trends
Table 11. Precision Cancer Medicine Market Drivers
Table 12. Precision Cancer Medicine Market Challenges
Table 13. Precision Cancer Medicine Market Restraints
Table 14. Global Precision Cancer Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Precision Cancer Medicine Market Share by Players (2019-2024)
Table 16. Global Top Precision Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Medicine as of 2023)
Table 17. Ranking of Global Top Precision Cancer Medicine Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Precision Cancer Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Precision Cancer Medicine Product Solution and Service
Table 21. Date of Enter into Precision Cancer Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Precision Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Precision Cancer Medicine Revenue Market Share by Type (2019-2024)
Table 25. Global Precision Cancer Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Precision Cancer Medicine Revenue Market Share by Type (2025-2030)
Table 27. Global Precision Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Precision Cancer Medicine Revenue Market Share by Application (2019-2024)
Table 29. Global Precision Cancer Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Precision Cancer Medicine Revenue Market Share by Application (2025-2030)
Table 31. North America Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Precision Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Precision Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Precision Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Precision Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Precision Cancer Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Precision Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Precision Cancer Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Precision Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Precision Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Precision Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Precision Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 46. AbbVie Company Detail
Table 47. AbbVie Business Overview
Table 48. AbbVie Precision Cancer Medicine Product
Table 49. AbbVie Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 50. AbbVie Recent Development
Table 51. Johnson & Johnson Company Detail
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Precision Cancer Medicine Product
Table 54. Johnson & Johnson Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Precision Cancer Medicine Product
Table 59. Novartis Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Gilead Sciences Company Detail
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Precision Cancer Medicine Product
Table 64. Gilead Sciences Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Roche Company Detail
Table 67. Roche Business Overview
Table 68. Roche Precision Cancer Medicine Product
Table 69. Roche Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Bristol-Myers Squibb Company Detail
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Precision Cancer Medicine Product
Table 74. Bristol-Myers Squibb Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 75. Bristol-Myers Squibb Recent Development
Table 76. Amgen Company Detail
Table 77. Amgen Business Overview
Table 78. Amgen Precision Cancer Medicine Product
Table 79. Amgen Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 80. Amgen Recent Development
Table 81. AstraZeneca Company Detail
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Precision Cancer Medicine Product
Table 84. AstraZeneca Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 85. AstraZeneca Recent Development
Table 86. Merck & Co Company Detail
Table 87. Merck & Co Business Overview
Table 88. Merck & Co Precision Cancer Medicine Product
Table 89. Merck & Co Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 90. Merck & Co Recent Development
Table 91. Takeda Company Detail
Table 92. Takeda Business Overview
Table 93. Takeda Precision Cancer Medicine Product
Table 94. Takeda Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 95. Takeda Recent Development
Table 96. Merck KGaA Company Detail
Table 97. Merck KGaA Business Overview
Table 98. Merck KGaA Precision Cancer Medicine Product
Table 99. Merck KGaA Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 100. Merck KGaA Recent Development
Table 101. Seagen Company Detail
Table 102. Seagen Business Overview
Table 103. Seagen Precision Cancer Medicine Product
Table 104. Seagen Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 105. Seagen Recent Development
Table 106. Eli Lilly Company Detail
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Precision Cancer Medicine Product
Table 109. Eli Lilly Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Ono Pharmaceutical Company Detail
Table 112. Ono Pharmaceutical Business Overview
Table 113. Ono Pharmaceutical Precision Cancer Medicine Product
Table 114. Ono Pharmaceutical Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 115. Ono Pharmaceutical Recent Development
Table 116. Pfizer Company Detail
Table 117. Pfizer Business Overview
Table 118. Pfizer Precision Cancer Medicine Product
Table 119. Pfizer Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 120. Pfizer Recent Development
Table 121. GSK Company Detail
Table 122. GSK Business Overview
Table 123. GSK Precision Cancer Medicine Product
Table 124. GSK Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 125. GSK Recent Development
Table 126. Exelixis Company Detail
Table 127. Exelixis Business Overview
Table 128. Exelixis Precision Cancer Medicine Product
Table 129. Exelixis Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 130. Exelixis Recent Development
Table 131. Regeneron Company Detail
Table 132. Regeneron Business Overview
Table 133. Regeneron Precision Cancer Medicine Product
Table 134. Regeneron Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 135. Regeneron Recent Development
Table 136. Innovent Company Detail
Table 137. Innovent Business Overview
Table 138. Innovent Precision Cancer Medicine Product
Table 139. Innovent Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 140. Innovent Recent Development
Table 141. Hengrui Medicine Company Detail
Table 142. Hengrui Medicine Business Overview
Table 143. Hengrui Medicine Precision Cancer Medicine Product
Table 144. Hengrui Medicine Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)
Table 145. Hengrui Medicine Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Cancer Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Precision Cancer Medicine Market Share by Type: 2023 VS 2030
Figure 3. Cancer Immunotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Global Precision Cancer Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Precision Cancer Medicine Market Share by Application: 2023 VS 2030
Figure 7. Lung Cancer Case Studies
Figure 8. Breast Cancer Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Blood-related Cancer Case Studies
Figure 11. Other Case Studies
Figure 12. Precision Cancer Medicine Report Years Considered
Figure 13. Global Precision Cancer Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Precision Cancer Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Precision Cancer Medicine Market Share by Region: 2023 VS 2030
Figure 16. Global Precision Cancer Medicine Market Share by Players in 2023
Figure 17. Global Top Precision Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Medicine as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Precision Cancer Medicine Revenue in 2023
Figure 19. North America Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Precision Cancer Medicine Market Share by Country (2019-2030)
Figure 21. United States Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Precision Cancer Medicine Market Share by Country (2019-2030)
Figure 25. Germany Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Precision Cancer Medicine Market Share by Region (2019-2030)
Figure 33. China Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Precision Cancer Medicine Market Share by Country (2019-2030)
Figure 41. Mexico Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Precision Cancer Medicine Market Share by Country (2019-2030)
Figure 45. Turkey Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. AbbVie Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 50. Gilead Sciences Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 53. Amgen Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 54. AstraZeneca Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 55. Merck & Co Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 56. Takeda Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 57. Merck KGaA Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 58. Seagen Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 59. Eli Lilly Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 60. Ono Pharmaceutical Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 61. Pfizer Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 62. GSK Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 63. Exelixis Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 64. Regeneron Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 65. Innovent Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 66. Hengrui Medicine Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed